Enveric Biosciences (NASDAQ:ENVB – Get Free Report) issued its earnings results on Monday. The company reported ($0.25) EPS for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.30, Yahoo Finance reports.
Enveric Biosciences Trading Down 7.8 %
ENVB stock traded down $0.04 during mid-day trading on Wednesday, reaching $0.49. The company’s stock had a trading volume of 162,555 shares, compared to its average volume of 2,381,886. The company’s 50 day moving average is $0.58 and its two-hundred day moving average is $0.83. Enveric Biosciences has a fifty-two week low of $0.41 and a fifty-two week high of $2.92. The stock has a market cap of $3.90 million, a PE ratio of -0.08 and a beta of 0.74.
Enveric Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Enveric Biosciences
- How to Calculate Return on Investment (ROI)
- Brinker International’s Price Dip is an Appetizing Entry Point
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Stocks That Could Beat the September Blues
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.